Roth/MKM Starts Terns Pharmaceuticals (TERN) at Buy, 'To the Liver and Beyond'
Tweet Send to a Friend
(Updated - May 30, 2023 4:37 PM EDT)
Roth/MKM analyst Dylan Dupuls initiates coverage on Terns Pharmaceuticals (NASDAQ: TERN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Roth/MKM analyst Dylan Dupuls initiates coverage on Terns Pharmaceuticals (NASDAQ: TERN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
